Fadia T Shaya1, Mark S Maneval2, Confidence M Gbarayor2, Kyongsei Sohn2, Anand A Dalal3, Dongyi Du2, Steven M Scharf4. 1. Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD. Electronic address: fshaya@rx.umaryland.edu. 2. Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD. 3. GlaxoSmithKline, Research Triangle Park, NC. 4. Sleep Disorders Center, University of Maryland School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Asthma and COPD are characterized by substantial racial disparities in morbidity and mortality. We hypothesized that because African-American patients with these conditions experience greater mortality and morbidity than their white counterparts, they would use more health-care resources when no difference in health insurance exists. METHODS: A retrospective, population-based cohort study was conducted using Maryland Medicaid Managed Care patient encounter data. We compared health services utilization and cost outcomes in both African-American and white patients with COPD, asthma, or coexisting COPD and asthma. RESULTS: The study population consisted of 9,131 patients with COPD, asthma, or both conditions. Of the total population, 52% were African American (n = 4,723), and 44% were white (n = 4,021); all other races were combined into the "unknown race" category to account for the remaining 4% (n = 387). After controlling for age, gender, cohort allocation, and comorbidities, we found that African-American adults with COPD, asthma, or coexisting COPD and asthma actually used fewer medical services and accounted for lower medical costs than white adults. CONCLUSIONS: Lower health services utilization and medical costs among African-American patients with COPD and asthma may provide a possible explanation for the racial disparities in outcomes of patients with these conditions.
BACKGROUND:Asthma and COPD are characterized by substantial racial disparities in morbidity and mortality. We hypothesized that because African-American patients with these conditions experience greater mortality and morbidity than their white counterparts, they would use more health-care resources when no difference in health insurance exists. METHODS: A retrospective, population-based cohort study was conducted using Maryland Medicaid Managed Care patient encounter data. We compared health services utilization and cost outcomes in both African-American and white patients with COPD, asthma, or coexisting COPD and asthma. RESULTS: The study population consisted of 9,131 patients with COPD, asthma, or both conditions. Of the total population, 52% were African American (n = 4,723), and 44% were white (n = 4,021); all other races were combined into the "unknown race" category to account for the remaining 4% (n = 387). After controlling for age, gender, cohort allocation, and comorbidities, we found that African-American adults with COPD, asthma, or coexisting COPD and asthma actually used fewer medical services and accounted for lower medical costs than white adults. CONCLUSIONS: Lower health services utilization and medical costs among African-American patients with COPD and asthma may provide a possible explanation for the racial disparities in outcomes of patients with these conditions.
Authors: Tracy A Lieu; Paula Lozano; Jonathan A Finkelstein; Felicia W Chi; Nancy G Jensvold; Angela M Capra; Charles P Quesenberry; Joe V Selby; Harold J Farber Journal: Pediatrics Date: 2002-05 Impact factor: 7.124
Authors: Nadia N Hansel; George R Washko; Marilyn G Foreman; MeiLan K Han; Eric A Hoffman; Dawn L DeMeo; R Graham Barr; Edwin J R Van Beek; Ella A Kazerooni; Robert A Wise; Robert H Brown; Jennifer Black-Shinn; John E Hokanson; Nicola A Hanania; Barry Make; Edwin K Silverman; James D Crapo; Mark T Dransfield Journal: COPD Date: 2013-02 Impact factor: 2.409
Authors: Carina J Gronlund; Antonella Zanobetti; Gregory A Wellenius; Joel D Schwartz; Marie S O'Neill Journal: Clim Change Date: 2016-03-07 Impact factor: 4.743
Authors: Surya P Bhatt; James M Wells; Victor Kim; Gerard J Criner; Craig P Hersh; Megan Hardin; William C Bailey; Hrudaya Nath; Young-Il Kim; Marilyn G Foreman; Douglas S Stinson; Carla G Wilson; Stephen I Rennard; Edwin K Silverman; Barry J Make; Mark T Dransfield Journal: Lancet Respir Med Date: 2014-09-09 Impact factor: 30.700
Authors: Daniel B Jamieson; Elizabeth C Matsui; Andrew Belli; Meredith C McCormack; Eric Peng; Simon Pierre-Louis; Jean Curtin-Brosnan; Patrick N Breysse; Gregory B Diette; Nadia N Hansel Journal: Am J Respir Crit Care Med Date: 2013-07-15 Impact factor: 21.405
Authors: A James Mamary; Jeffery I Stewart; Gregory L Kinney; John E Hokanson; Kartik Shenoy; Mark T Dransfield; Marilyn G Foreman; Gwendolyn B Vance; Gerard J Criner Journal: Chronic Obstr Pulm Dis Date: 2018-07-02
Authors: Kerry A Spitzer; Mihaela S Stefan; Aruna Priya; Quinn R Pack; Penelope S Pekow; Tara Lagu; Kathy M Mazor; Victor M Pinto-Plata; Richard L ZuWallack; Peter K Lindenauer Journal: Chest Date: 2020-01-17 Impact factor: 9.410
Authors: Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au Journal: BMC Health Serv Res Date: 2011-02-16 Impact factor: 2.655